Like Finding a Needle in a Haystack: How Are Biotechs Fighting Rare Diseases?
Rare diseases affect fewer than 1 in 2,000 people in Europe and less than 200,000…
February 28, 2018 - 8 minutes
Hemophilia
How is Biotech Innovating to Treat Hemophilia? Let’s Review
Experts say hemophilia treatment is at a 'precipice of a therapeutic revolution.' From antibodies to…
February 13, 2018 - 7 minutes
Interviews, Reviews and Tops: Our Best Biotech Articles from 2017
We love hearing from our readers, and we listen to what they like! Here are…
December 26, 2017 - 6 minutes
This Gene Therapy for Hemophilia Can Reduce Bleeding by 70%
UniQure has published clinical data revealing that its gene therapy for hemophilia B is effective…
December 19, 2017 - 3 minutes
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Now that we've got the bad news out of the way, we're here to spread…
December 18, 2017 - 9 minutes
Reviewing Gene Therapy: How Close is Biotech to Genetic Cures?
Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix…
November 28, 2017 - 8 minutes
Close to Launching Gene Therapy, Dutch Biotech Raises Over $91M on the Nasdaq
Update (2/11/2017): uniQure has closed its public offering raising over $91m (€78M) on the Nasdaq, taking advantage…
November 2, 2017 - 3 minutes
Dutch Biotech plans Pivotal Clinical Trial with First Gene Therapy for Hemophilia
uniQure is getting ready to start a Phase III clinical trial in 2018 with a…
October 19, 2017 - 2 minutes
A €344M Partnership will Develop Bicycle Drugs for Hemophilia
Bicycle Therapeutics has partnered with Bioverativ to develop a new class of drugs for patients…
September 6, 2017 - 2 minutes
Shire In-Licenses Swiss Antibody for Hemophilia A to Compete with Roche
Shire has bought exclusive worldwide rights to develop and commercialize a bispecific antibody from Novimmune…
July 18, 2017 - 2 minutes
Sanofi and US Partner Launch Phase III Trial in Hemophilia with RNAi
Alnylam and its partner Sanofi are starting a Phase III program to enter its RNAi…
July 10, 2017 - 3 minutes
Discussing the Virtual Biotech Model with XO1 Co-Founder Trevor Baglin
Academic, entrepreneur and now venture partner Trevor Baglin discusses his successful experience working with…
June 19, 2017 - 7 minutes
